12 C
Lahore
Friday, November 28, 2025

Lenzing going high in difficult market environment

Despite a generally difficult demand environment for textile fibers and a drastic drop in prices for standard viscose, the Lenzing Group recorded a solid business development in 2019. The disciplined implementation of the sCore TEN corporate strategy and the accompanying focus on specialty fibers once again helped to mitigate the effect of unprecedentedly low standard viscose prices.

purchase lioresal online in the best USA pharmacy https://www.immunitytherapycenter.com/wp-content/uploads/2025/09/html/purchase-lioresal.html no prescription with fast delivery drugstore

Lenzing AG

As a result, revenue dropped by 3.3 percent from EUR 2.18 bn to EUR 2.11 bn in 2019, driven by lower selling prices as well as standard fiber volumes.

buy mounjaro online in the best USA pharmacy https://andreakrafft.com/wp-content/uploads/2025/09/html/buy-mounjaro.html no prescription with fast delivery drugstore

Due to positive mix effects and more resilient specialty fiber prices, the share of specialty fibers increased from 45.5 percent to 51.6 percent of revenue. The earnings development was largely influenced by the decline in revenue, but also by negative currency effects on material and personnel costs. EBITDA (earnings before interest, tax, depreciation and amortization) fell by 14.

buy bactroban online simpsonmedical.com/wp-content/uploads/2024/07/png/bactroban.html no prescription pharmacy

4 percent from EUR 382 mn to EUR 326.9 mn. The EBITDA margin declined from 17.6 percent to 15.5 percent. Net profit, at EUR 114.9 mn, was 22.4 percent lower than in the previous year at EUR 148.

buy mounjaro online simpsonmedical.com/wp-content/uploads/2024/07/png/mounjaro.html no prescription pharmacy

2 mn. Earnings per share amounted to EUR 4.63 (2018: EUR 5.61).

The Management Board proposed at the 76th Annual General Meeting a dividend of EUR 1.

buy rogaine online simpsonmedical.com/wp-content/uploads/2024/07/png/rogaine.html no prescription pharmacy

00 per share for the 2019 financial year (2018: dividend of EUR 3.00 plus a special dividend of EUR 2.00 per share), which is equivalent to a total dividend payout of EUR 26.6 mn. The Supervisory Board accepted this proposal at its meeting held on March 11, 2020.

Related Articles

2 COMMENTS

Stay Connected

11,285FansLike
394FollowersFollow
9,950SubscribersSubscribe

Latest Articles